Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Leerink Partnrs lowered shares of Harpoon Therapeutics (NASDAQ:HARP – Free Report) from an outperform rating to a market perform rating in a research report released on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Harpoon Therapeutics’ FY2025 earnings at ($2.09) EPS. Several other brokerages have also commented on HARP. Oppenheimer started coverage on Harpoon […]
Harpoon Therapeutics, Inc. (NASDAQ:HARP – Free Report) – Equities research analysts at HC Wainwright issued their FY2028 earnings estimates for shares of Harpoon Therapeutics in a research report issued on Monday, January 8th. HC Wainwright analyst S. Ramakanth forecasts that the company will earn $1.58 per share for the year. HC Wainwright currently has a […]
Harpoon Therapeutics, Inc. (NASDAQ:HARP – Free Report) – Research analysts at Leerink Partnrs issued their FY2025 EPS estimates for Harpoon Therapeutics in a research note issued to investors on Monday, January 8th. Leerink Partnrs analyst J. Chang expects that the company will post earnings of ($2.09) per share for the year. Leerink Partnrs currently has […]